Global Meningococcal Polysaccharide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 93

Published Date: 02 Apr 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Meningococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Meningococcal Polysaccharide Vaccine market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. 6 Months-15Year accounting for % of the Meningococcal Polysaccharide Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polysaccharide Meningtitis AC segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Meningococcal Polysaccharide Vaccine include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, and Chongqing Zhifei Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Market segment by Application can be divided into
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

The key market players for global Meningococcal Polysaccharide Vaccine market are listed below:
    Sanofi
    Bio-Med
    CanSinoBIO
    Walvax Biotechnology
    Chongqing Zhifei Biological
    Chengdu Kanghua Biological Products
    Changsheng Biotechnology
    CanSinoBIO

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Polysaccharide Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Meningococcal Polysaccharide Vaccine from 2019 to 2022.
Chapter 3, the Meningococcal Polysaccharide Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Polysaccharide Vaccine.
Chapter 13, 14, and 15, to describe Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Meningococcal Polysaccharide Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Meningococcal Polysaccharide Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Polysaccharide Meningtitis AC
        1.2.3 Meningitis ACYW
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Meningococcal Polysaccharide Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 6 Months-15Year
        1.3.3 over 3 Year
        1.3.4 over 2 Year
        1.3.5 over 3 Months
    1.4 Global Meningococcal Polysaccharide Vaccine Market Size & Forecast
        1.4.1 Global Meningococcal Polysaccharide Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Meningococcal Polysaccharide Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Meningococcal Polysaccharide Vaccine Price (2017-2028)
    1.5 Global Meningococcal Polysaccharide Vaccine Production Capacity Analysis
        1.5.1 Global Meningococcal Polysaccharide Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Meningococcal Polysaccharide Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Meningococcal Polysaccharide Vaccine Market Drivers
        1.6.2 Meningococcal Polysaccharide Vaccine Market Restraints
        1.6.3 Meningococcal Polysaccharide Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
        2.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Bio-Med
        2.2.1 Bio-Med Details
        2.2.2 Bio-Med Major Business
        2.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
        2.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 CanSinoBIO
        2.3.1 CanSinoBIO Details
        2.3.2 CanSinoBIO Major Business
        2.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        2.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Walvax Biotechnology
        2.4.1 Walvax Biotechnology Details
        2.4.2 Walvax Biotechnology Major Business
        2.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        2.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Chongqing Zhifei Biological
        2.5.1 Chongqing Zhifei Biological Details
        2.5.2 Chongqing Zhifei Biological Major Business
        2.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
        2.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Chengdu Kanghua Biological Products
        2.6.1 Chengdu Kanghua Biological Products Details
        2.6.2 Chengdu Kanghua Biological Products Major Business
        2.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
        2.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Changsheng Biotechnology
        2.7.1 Changsheng Biotechnology Details
        2.7.2 Changsheng Biotechnology Major Business
        2.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        2.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 CanSinoBIO
        2.8.1 CanSinoBIO Details
        2.8.2 CanSinoBIO Major Business
        2.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        2.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Meningococcal Polysaccharide Vaccine Breakdown Data by Manufacturer
    3.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Meningococcal Polysaccharide Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2021
    3.5 Global Meningococcal Polysaccharide Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Meningococcal Polysaccharide Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region
        4.1.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
    4.2 North America Meningococcal Polysaccharide Vaccine Revenue (2017-2028)
    4.3 Europe Meningococcal Polysaccharide Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue (2017-2028)
    4.5 South America Meningococcal Polysaccharide Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Meningococcal Polysaccharide Vaccine Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
    5.3 Global Meningococcal Polysaccharide Vaccine Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
    6.3 Global Meningococcal Polysaccharide Vaccine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
    7.2 North America Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
    7.3 North America Meningococcal Polysaccharide Vaccine Market Size by Country
        7.3.1 North America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
    8.2 Europe Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
    8.3 Europe Meningococcal Polysaccharide Vaccine Market Size by Country
        8.3.1 Europe Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Market Size by Region
        9.3.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
    10.2 South America Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
    10.3 South America Meningococcal Polysaccharide Vaccine Market Size by Country
        10.3.1 South America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Market Size by Country
        11.3.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Meningococcal Polysaccharide Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Meningococcal Polysaccharide Vaccine
    12.3 Meningococcal Polysaccharide Vaccine Production Process
    12.4 Meningococcal Polysaccharide Vaccine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Meningococcal Polysaccharide Vaccine Typical Distributors
    13.3 Meningococcal Polysaccharide Vaccine Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Meningococcal Polysaccharide Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Meningococcal Polysaccharide Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
    Table 6. Sanofi Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 8. Bio-Med Major Business
    Table 9. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
    Table 10. Bio-Med Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 12. CanSinoBIO Major Business
    Table 13. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 14. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 16. Walvax Biotechnology Major Business
    Table 17. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 18. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
    Table 20. Chongqing Zhifei Biological Major Business
    Table 21. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
    Table 22. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
    Table 24. Chengdu Kanghua Biological Products Major Business
    Table 25. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
    Table 26. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 28. Changsheng Biotechnology Major Business
    Table 29. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 30. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 32. CanSinoBIO Major Business
    Table 33. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 34. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Global Meningococcal Polysaccharide Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
    Table 36. Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 37. Market Position of Manufacturers in Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 38. Global Meningococcal Polysaccharide Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
    Table 39. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
    Table 40. Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
    Table 41. Meningococcal Polysaccharide Vaccine Mergers & Acquisitions in the Past Five Years
    Table 42. Global Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 43. Global Meningococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 44. Global Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 45. Global Meningococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 46. Global Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 47. Global Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 48. Global Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (USD Million)
    Table 49. Global Meningococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (USD Million)
    Table 50. Global Meningococcal Polysaccharide Vaccine Price by Type (2017-2022) & (US$/Dose)
    Table 51. Global Meningococcal Polysaccharide Vaccine Price by Type (2023-2028) & (US$/Dose)
    Table 52. Global Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 53. Global Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 54. Global Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (USD Million)
    Table 55. Global Meningococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (USD Million)
    Table 56. Global Meningococcal Polysaccharide Vaccine Price by Application (2017-2022) & (US$/Dose)
    Table 57. Global Meningococcal Polysaccharide Vaccine Price by Application (2023-2028) & (US$/Dose)
    Table 58. North America Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 59. North America Meningococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 60. North America Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 61. North America Meningococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 62. North America Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 63. North America Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 64. North America Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 65. North America Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 66. Europe Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 67. Europe Meningococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 68. Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 69. Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 70. Europe Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 71. Europe Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 72. Europe Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 73. Europe Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 74. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 75. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 76. Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 77. Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 78. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 79. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 80. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 81. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 82. South America Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 83. South America Meningococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 84. South America Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 85. South America Meningococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 86. South America Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 87. South America Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 88. South America Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 89. South America Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 90. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 91. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 92. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 93. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 94. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 95. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 96. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 97. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 98. Meningococcal Polysaccharide Vaccine Raw Material
    Table 99. Key Manufacturers of Meningococcal Polysaccharide Vaccine Raw Materials
    Table 100. Direct Channel Pros & Cons
    Table 101. Indirect Channel Pros & Cons
    Table 102. Meningococcal Polysaccharide Vaccine Typical Distributors
    Table 103. Meningococcal Polysaccharide Vaccine Typical Customers
List of Figures
    Figure 1. Meningococcal Polysaccharide Vaccine Picture
    Figure 2. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type in 2021
    Figure 3. Polysaccharide Meningtitis AC
    Figure 4. Meningitis ACYW
    Figure 5. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
    Figure 6. 6 Months-15Year
    Figure 7. over 3 Year
    Figure 8. over 2 Year
    Figure 9. over 3 Months
    Figure 10. Global Meningococcal Polysaccharide Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
    Figure 11. Global Meningococcal Polysaccharide Vaccine Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Meningococcal Polysaccharide Vaccine Sales (2017-2028) & (K Doses)
    Figure 13. Global Meningococcal Polysaccharide Vaccine Price (2017-2028) & (US$/Dose)
    Figure 14. Global Meningococcal Polysaccharide Vaccine Production Capacity (2017-2028) & (K Doses)
    Figure 15. Global Meningococcal Polysaccharide Vaccine Production Capacity by Geographic Region: 2022 VS 2028
    Figure 16. Meningococcal Polysaccharide Vaccine Market Drivers
    Figure 17. Meningococcal Polysaccharide Vaccine Market Restraints
    Figure 18. Meningococcal Polysaccharide Vaccine Market Trends
    Figure 19. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2021
    Figure 20. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2021
    Figure 21. Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 22. Top 3 Meningococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 23. Top 6 Meningococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 24. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
    Figure 25. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
    Figure 26. North America Meningococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
    Figure 27. Europe Meningococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
    Figure 28. Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
    Figure 29. South America Meningococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
    Figure 30. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
    Figure 31. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 32. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 33. Global Meningococcal Polysaccharide Vaccine Price by Type (2017-2028) & (US$/Dose)
    Figure 34. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. Global Meningococcal Polysaccharide Vaccine Price by Application (2017-2028) & (US$/Dose)
    Figure 37. North America Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 38. North America Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 39. North America Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
    Figure 40. North America Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
    Figure 41. United States Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Canada Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Mexico Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 45. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 46. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
    Figure 47. Europe Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
    Figure 56. Asia-Pacific Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
    Figure 57. China Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Japan Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Korea Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. India Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Southeast Asia Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Australia Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South America Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 64. South America Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 65. South America Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
    Figure 66. South America Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
    Figure 67. Brazil Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Argentina Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 70. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
    Figure 72. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
    Figure 73. Turkey Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Egypt Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. South Africa Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2021
    Figure 78. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
    Figure 79. Meningococcal Polysaccharide Vaccine Industrial Chain
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO

Related Reports

Global Meningococcal Polysaccharide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Meningococcal Polysaccharide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

date 24 Jan 2023

date Pharma & Healthcare

The global Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

meningococcal polysaccharide vaccine

group acyw135 meningococcal polysaccharide vaccine

group acyw135 meningococcal polysaccharide vaccine production demand producers

Group A and Group C Meningococcal Polysaccharide Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>